Clinical Trials Directory

Trials / Unknown

UnknownNCT02069587

Pomegranate to Reduce Maternal and Fetal Oxidative Stress and to Improve Outcome in Pregnancies Complicated With Preterm Premature Rupture of Membranes

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Hillel Yaffe Medical Center · Other Government
Sex
Female
Age
18 Years – 44 Years
Healthy volunteers
Not accepted

Summary

Preterm premature rupture of membrane is associated with increased oxidative stress and inflammatory process, enhancing the activity or the availability of antioxidants may modulate the inflammatory response associated with PPROM, thereby reducing oxidative stress and the risk to the fetus. In this study the investigators sought to determine the effects of Pomegranate 1. On the patients (maternal and fetal) oxidative stress and inflammation associated with PPROM. 2. On the time interval from PPROM to delivery and on the patients (fetal )Ph and apger scores

Detailed description

In this study the investigators sought to determine the effects of Pomegranate 1. On the patients (maternal and fetal )oxidative stress and inflammation associated with PPROM. 2. On the time interval from PPROM to delivery and on the patients (fetal )Ph and apger scores

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTpomegranate

Timeline

Start date
2014-02-01
Primary completion
2015-02-01
Completion
2015-04-01
First posted
2014-02-24
Last updated
2014-02-24

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02069587. Inclusion in this directory is not an endorsement.